Search results
Showing 1141 to 1155 of 1877 results for do not dos
Axicabtagene ciloleucel for treating relapsed or refractory follicular lymphoma (TA894)
Evidence-based recommendations on axicabtagene ciloleucel (Yescarta) for relapsed or refractory follicular lymphoma in adults.
evidence for the use of progesterone to reduce preterm birth, however studies do not define the optimal gestational age that this...
that doctors often fail to identify high-risk patients before surgery and do not provide perioperative interventions to control HbA1c...
NICE has developed a medtech innovation briefing (MIB) on the needle-free arterial non-injectable connector .
NICE has developed a medtech innovation briefing (MIB) on URO17 for detecting bladder cancer .
This guideline covers how to identify adults at high risk of type 2 diabetes. It aims to remind practitioners that age is no barrier to being at high risk of, or developing, the condition. It also aims to help them provide those at high risk with an effective and appropriate intensive lifestyle-change programme to prevent or delay the onset of type 2 diabetes. The recommendations in this guideline can be used alongside the NHS Health Check programme .
Processes and methods for NICE-wide guidance surveillance (PMG49)
This guide describes the methods and processes that NICE follows to assess the impact of new evidence, changes to the health and care system, or other new, relevant information that has come to light after NICE guidance has published
Evidence-based recommendations on percutaneous intradiscal radiofrequency treatment of the intervertebral disc nucleus for low back pain. This involves relieving low back pain by delivering heat energy to the damaged disc.
socioeconomic areas, where patients attend irregularly (or cannot afford to attend) or do not place a high priority on disease...
medicines in people's recovery, the committee recommended opportunities to do this for those assessed as able to take part. Because of...
disease is difficult in younger children. Not all children under 5 years can do spirometry tests and they are not sufficiently sensitive...
Evidence-based recommendations on pegunigalsidase alfa (Elfabrio) for Fabry disease (also known as alpha-galactosidase deficiency) in adults.
Evidence-based recommendations on pembrolizumab (Keytruda) with trastuzumab and chemotherapy for untreated locally advanced unresectable or metastatic HER2-positive gastric or gastro-oesophageal junction adenocarcinoma in adults.
Evidence-based recommendations on niraparib (Zejula) for treating relapsed, platinum-sensitive high-grade serous epithelial ovarian, fallopian tube or primary peritoneal cancer in adults.
Avapritinib for treating advanced systemic mastocytosis (TA1012)
Evidence-based recommendations on avapritinib (Ayvakyt) for treating advanced systemic mastocytosis in adults.